Evolocumab is a human monoclonal antibody that inhibits PCSK9, preventing its interaction with the LDL receptor. It is widely used in preclinical and clinical research for studying hypercholesterolemia and atherosclerotic cardiovascular disease, including in vitro binding assays and in vivo models of lipid metabolism.
Konzentration:
140 mg/mL
Molekulargewicht:
144 kDa
Reinheit:
98.30% (May vary between batches)
CAS Nummer:
[1256937-27-5]
Target-Kategorie:
NF-kappaB,TLR,Serine Protease,Others,LDLR
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten